<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04807712</url>
  </required_header>
  <id_info>
    <org_study_id>ACT0606</org_study_id>
    <nct_id>NCT04807712</nct_id>
  </id_info>
  <brief_title>Pediatric Pertussis in Ambulatory Settings</brief_title>
  <acronym>ACTIVCOQ</acronym>
  <official_title>National Surveillance of Pediatric Pertussis in Ambulatory Settings</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Association Clinique Thérapeutique Infantile du val de Marne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sanofi</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Association Clinique Thérapeutique Infantile du val de Marne</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Since 2002, Whooping cough surveillance in pediatric private practice has been set up in&#xD;
      France. The results of the first years, 2002-2006, have confirmed the effectiveness of the&#xD;
      Pertussis whole-cell (Pw) vaccine and in particular the duration of protection of 9/10 years.&#xD;
      After evaluating cases in children vaccinated with Pw vaccines, the study aims today to&#xD;
      analyze cases in children vaccinated with Pertussis acellular (Pa) vaccines used since&#xD;
      2002/2003 and to assess, on an outpatient basis, the impact of new vaccine recommendations in&#xD;
      France (in 2013, introduction of a 2 + 1 schedule - 8 weeks, 4 months and a 11-month recall -&#xD;
      and a 6-year recall, and in 2014, update in the recommendations of exams to be prescribed&#xD;
      based on the child's age and vaccination status).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The whooping cough surveillance objectives are :&#xD;
&#xD;
        -  to follow the duration of protection of the Ca vaccines in the context of modifications&#xD;
           of the vaccine recommendations&#xD;
&#xD;
        -  to describe the clinical characteristics of a population vaccinated with several&#xD;
           boosters&#xD;
&#xD;
        -  to adapt complementary examinations for diagnostic purposes (culture, PCR, serology)&#xD;
           according to the evolution of scientific knowledge&#xD;
&#xD;
        -  to monitor B. parapertussis infections&#xD;
&#xD;
        -  to train laboratories with nasopharyngeal aspiration&#xD;
&#xD;
        -  to monitor the evolution of the bacterial species All children aged 0-18 years, in whom&#xD;
           the diagnosis of pertussis is mentioned and for which a biological check-up is&#xD;
           requested, are included, except asymptomatic children with confirmed family case.&#xD;
&#xD;
      In case of suspected pertussis, real-time PCR and / or culture and / or (rarely) serology is&#xD;
      / are still prescribed to the patient and / or his entourage.&#xD;
&#xD;
      Selected Pediatricians from the ACTIV group and the AFPA working in an outpatient clinic,&#xD;
      located in different places in France, are participating in this network since 2001. The&#xD;
      clinical evolution and the results of the examinations are transcribed on a case report form.&#xD;
      The data are collected, firstly, during the visit where the diagnosis of whooping cough is&#xD;
      suspected and a biological assessment requested (patient's medical history, clinical data,&#xD;
      vaccination status and dates, as well as the search for a contaminated/contaminator) and&#xD;
      secondly during the follow-up visit (results of the biological check-up and diagnosis,&#xD;
      antibiotics potentially prescribed, and supplement data of the entourage, except in case of&#xD;
      diagnosis of pertussis not retained).&#xD;
&#xD;
      All evaluations made by the pediatricians are regularly reviewed during meetings, and final&#xD;
      diagnoses used are:&#xD;
&#xD;
        -  biological pertussis&#xD;
&#xD;
        -  epidemiological pertussis&#xD;
&#xD;
        -  not evaluable&#xD;
&#xD;
        -  lost of follow up&#xD;
&#xD;
        -  no whooping cough&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2002</start_date>
  <completion_date type="Anticipated">January 1, 2025</completion_date>
  <primary_completion_date type="Actual">January 1, 2002</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of pertussis vaccines protection</measure>
    <time_frame>at inclusion</time_frame>
    <description>Evaluate the duration of protection of the Ca vaccines</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical characteristics of pertussis</measure>
    <time_frame>at inclusion</time_frame>
    <description>Describe the clinical characteristics of a population vaccinated</description>
  </secondary_outcome>
  <enrollment type="Anticipated">874</enrollment>
  <condition>Pertussis/Whooping Cough</condition>
  <condition>Children, Only</condition>
  <condition>Ambulatory</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>non interventionnal study</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        children under 18 years with suspected pertussis diagnosis&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All children under 18 years old with a pertussis diagnosis is suspected and a&#xD;
             biological exam is requested&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  children without symptoms with a houshold confirmed case&#xD;
&#xD;
          -  cases for which the pertussis diagnosis was not suspected by the pediatrician&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Corinne Levy, MD</last_name>
    <phone>0033148850404</phone>
    <email>corinne.levy@activ-france.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stéphane Béchet, MsC</last_name>
    <phone>0033148850404</phone>
    <email>stephane.bechet@activ-france.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>ACTIV</name>
      <address>
        <city>Créteil</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Corinne Levy, MD</last_name>
      <phone>0033148850404</phone>
      <email>corinne.levy@activ-france.fr</email>
    </contact>
    <contact_backup>
      <last_name>Stéphane Béchet, MSc</last_name>
      <phone>0033148850404</phone>
      <email>stephane.bechet@activ-france.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/28974408/</url>
    <description>Whooping cough surveillance in France in pediatric private practice in 2006-2015</description>
  </link>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/18598649/</url>
    <description>Pertussis surveillance in private pediatric practices, France, 2002-2006</description>
  </link>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/14550985/</url>
    <description>Guidelines for diagnosis of whooping cough</description>
  </link>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 18, 2021</study_first_submitted>
  <study_first_submitted_qc>March 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 19, 2021</study_first_posted>
  <last_update_submitted>March 19, 2021</last_update_submitted>
  <last_update_submitted_qc>March 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pertussis</keyword>
  <keyword>surveillance</keyword>
  <keyword>pertussis acellular vaccine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Whooping Cough</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

